Surgery Support; Before and After Care
Evidence-based perioperative guidance for cancer patients before and after surgery
Surgery can be necessary, life-saving, and sometimes curative.
They can also create a short biological window in which inflammation rises, immune surveillance drops, and residual tumour cells may gain an advantage.
This page focuses on the practical perioperative questions that matter most before and after cancer surgery.
Use this page when planning around:
lumpectomy
mastectomy
tumour resection
debulking surgery
other cancer-related procedures
The goal is not to avoid surgery when it is needed.
The goal is to reduce avoidable perioperative risk.
Why surgery can increase recurrence risk
Surgery removes the tumour.
It also creates tissue injury, stress signalling, and a wound-healing response.
That matters because the perioperative period can temporarily favour the survival of residual cancer cells.
Main mechanisms
Surgical immunosuppression — NK-cell and T-cell activity can fall after major tissue injury.
Adrenergic stress signalling — catecholamines rise and may support tumour-cell survival, migration, and immune evasion.
COX-2 and prostaglandin signalling — post-surgical inflammation may suppress anti-tumour immunity and support adhesion and angiogenesis.
Wound-healing stemness signals — normal repair biology may also support more aggressive behaviour in residual tumour cells.
Dormant micrometastatic outgrowth — some recurrence patterns suggest surgery can help trigger growth of previously controlled microscopic disease.
This is the biological rationale behind interest in perioperative beta-blockade, NSAID use, ERAS protocols, and anaesthetic choice.
What is worth monitoring
There is no single routine blood test for “surgical metastasis risk”.
Some perioperative markers are still worth following.
Inflammatory markers
CRP, IL-6, white cell count
Pre-op baseline, then early post-op
Higher inflammation often tracks with worse recovery biology
NK-cell activity
Specialist immune assay
Pre- and post-op when available
Research-level marker of immune competence
Galectin-3
Blood test
Pre-op and follow-up
Sometimes used when modified citrus pectin is being considered
Tumour markers
Standard blood tests such as CA15-3 or CEA
Baseline, then follow-up
Can help with early recurrence surveillance in selected cancers
Wound assessment
Clinical review
Post-op visits
Detects infection, seroma, dehiscence, and delayed healing
Nutritional status
Albumin, pre-albumin, BMI, intake review
Pre-op
Strongly affects recovery and wound healing
Ask the team what they routinely check.
If you are implementing a more deliberate perioperative protocol, it is reasonable to ask about inflammatory markers after surgery.
The strongest perioperative strategies
Propranolol plus etodolac
This is one of the most important evidence-backed perioperative combinations.
The rationale is dual blockade of:
beta-adrenergic stress signalling
COX-2-driven prostaglandin signalling
Human peri-operative trials have shown favourable effects on metastatic biomarkers, inflammatory markers, and tumour microenvironment signals.
A colorectal phase III trial also reported lower 5-year recurrence risk with combined propranolol plus etodolac.
This is promising.
It is not a self-directed protocol.
Important cautions:
propranolol is not suitable for everyone
asthma, hypotension, bradycardia, and some rhythm disorders matter
NSAID timing must be coordinated with the surgeon because of bleeding risk
this approach requires prescription-level oversight
The paper used short-term oral propranolol plus etodolac for 11 days around surgery, starting 5 days pre-op and continuing until 5 days post-op, with twice-daily dosing and titration over the first few days.
Dosing and schedule (brief, as per paper)
For early-stage breast cancer patients undergoing tumor resection, the trial protocol was:
Overall duration: 11 consecutive days of treatment, beginning 5 days before surgery and continuing through 5 days after surgery.
Agents: Non-selective β-blocker propranolol plus COX‑2–preferential inhibitor etodolac, both given orally.
Propranolol dose/schedule: 20 mg three times daily for the first 3 days, then escalated to 40 mg twice daily from day −2 (relative to surgery) through day +5 post-op, assuming tolerance and target heart rate/blood pressure were maintained.
Etodolac dose/schedule: 400 mg twice daily throughout the 11-day period, from day −5 to day +5 around surgery.
Adverse events were comparable to placebo, and the regimen was reported as well tolerated over this short peri-operative window. Peri-operative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients https://doi.org/10.1158/1078-0432.CCR-17-0152
Propofol-based TIVA
Anaesthetic choice may matter more than many patients are told.
Large observational studies and meta-analyses suggest propofol-based total intravenous anaesthesia (TIVA) may be associated with better cancer outcomes than volatile inhaled anaesthetics.
The likely reasons include effects on:
angiogenesis
inflammatory signalling
NK-cell preservation
tumour-cell invasion biology
This evidence is still mostly observational.
A definitive RCT answer is still pending.
Even so, asking the anaesthetist whether propofol-based TIVA is appropriate is a reasonable perioperative question.
ERAS protocol
Enhanced Recovery After Surgery (ERAS) is already guideline-backed.
This is not fringe.
It is mainstream perioperative optimisation.
Key parts include:
avoiding unnecessarily long fasting
allowing clear fluids closer to surgery where protocol permits
carbohydrate loading when appropriate
early mobilisation
early nutrition
immunonutrition in selected cases
ERAS helps reduce complications, shorten hospital stay, and blunt some of the surgical stress response.
Ask whether your hospital uses an ERAS pathway.
Integrative supports with early but incomplete evidence
These options have biologic rationale or early human signal, but most do not yet have large perioperative oncology RCT data.
Modified citrus pectin
Modified citrus pectin is used to target galectin-3, a molecule involved in adhesion and metastatic behaviour.
The main evidence is preclinical, with limited human data.
It is best understood as a plausible adjunct rather than a proven perioperative anti-metastatic tool.
Boswellia serrata
Boswellia has early human window-of-opportunity data showing reduced tumour proliferation markers in breast-cancer tissue.
That makes it more than a purely theoretical option.
It may be relevant before surgery due to its anti-inflammatory effects, including modulation of COX-2 and 5-LOX.
This still needs careful timing review with the surgical team.
There is also a more specific brain metastasis/cerebral oedema angle worth noting.
In irradiated brain-tumour patients, Boswellia has been studied for reducing cerebral oedema, with doses up to 4200 mg/day reported without major adverse effects. The main practical limitation was pill fatigue.
A later retrospective study in patients with cerebral radiation necrosis after stereotactic radiosurgery for brain metastases used target doses around 4050 to 4500 mg/day for at least 2 months. In that uncontrolled series, some patients had complete or partial regression of necrosis or oedema, while others remained stable or progressed.
This is not direct surgery-trial evidence.
It is still relevant for brain-metastasis patients because perioperative brain care often overlaps with radiation history, oedema control, and steroid-sparing questions.
The main practical takeaway is that higher Boswellia dosing has been used under specialist supervision in neuro-oncology settings, so standard supplement-label doses may not reflect the dose ranges studied for cerebral oedema.
For broader context, see Boswellia in Oncology.
Iodine
Molecular iodine has human breast-cancer data suggesting benefit when used around surgery, with changes in invasiveness, apoptosis, and immune infiltration.
This is not the same as casually using Lugol’s.
Form matters.
Dose matters.
Wound-healing nutrients
The strongest general wound-healing support evidence is around:
zinc
vitamin C
These are not cancer-specific breakthroughs.
They are basic recovery supports with reasonable evidence in wound-healing settings.
They may still be worth reviewing if nutritional status is poor.
Topical scar and wound support
Once the incision is fully closed, options with reasonable supportive use include:
silicone gel sheets
rosehip oil
aloe vera gel
These are mainly scar-management and skin-recovery tools.
They are not recurrence-prevention tools.
Pre-op stop list
This is one of the most practical parts of the page.
Many supplements that feel harmless in everyday life become relevant around surgery because they may affect:
bleeding
blood pressure
sedation
anaesthetic metabolism
platelet function
Always give the surgeon and anaesthetist a full medication and supplement list well before the procedure.
Common examples that are often paused about one week before surgery
These are commonly reviewed because of sedation, anaesthesia, or blood-pressure concerns:
St John’s wort
valerian
kava
ginseng
passion flower
hops
melatonin
5-HTP
GABA
ephedra
high-dose licorice root
ginkgo
Common examples often paused at least 3 days before surgery
These are commonly reviewed because of bleeding or clotting concerns:
garlic
bromelain
ginger
curcumin
salvia
reishi
cordyceps
CoQ10
resveratrol
green tea extract
high-dose vitamin E
The exact timing varies.
The surgical team needs to get the final say.
Post-op red flags
Escalate urgently for:
fever above 38°C within the first week after surgery
increasing redness, heat, swelling, or discharge from the wound
wound opening or rapidly worsening pain
shortness of breath or chest pain
major limb swelling
persistent vomiting that prevents fluid or medication intake
confusion, persistent drowsiness, or unexpected altered consciousness
a sharp and unexplained tumour-marker rise during follow-up
Do not wait for the next routine appointment if these happen.
Themes from group experience
The group discussion around surgery repeatedly highlights the same themes:
anaesthetic choice is often not discussed unless the patient raises it
supplement timing is frequently left too late
emotional preparation changes the recovery experience for many people
wound healing and scar outcome can differ a lot depending on surgical approach, nutrition, and post-op support
These are not substitutes for evidence.
They are still useful signals about what patients often wish they had asked earlier.
For the fuller community-sourced archive, see Surgery — Member Experiences & Open Questions.
Questions to ask your team
Is propofol-based TIVA appropriate for me?
Does the hospital use an ERAS protocol?
Are there any perioperative beta-blocker or NSAID strategies appropriate in my case?
Which supplements do you want me to stop, and on what date?
What is the planned surgical approach, and what are the cosmetic versus tissue-trauma trade-offs?
What do you want me to watch for in the first week after surgery?
Which inflammatory or recovery markers are worth checking after surgery?
If I am nutritionally depleted, what is the plan for wound-healing support?
Bottom line
The perioperative period is not passive downtime.
It is an active biological phase that can influence inflammation, immunity, healing, and possibly recurrence risk.
The most evidence-supported practical priorities are:
ask about propofol-based TIVA
ask whether your care follows ERAS principles
review whether propranolol plus etodolac is appropriate in your case
stop bleeding-risk and anaesthetic-interaction supplements on time
treat wound infection and clotting symptoms as urgent
Integrative supports such as modified citrus pectin, Boswellia, iodine, and wound-healing nutrients may have a place.
They are best treated as adjuncts, not substitutes for perioperative medical planning.
Key References
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors https://doi.org/10.1126/scitranslmed.aan3464
Surgical trauma-induced immunosuppression in cancer https://doi.org/10.1002/ctm2.24
Perioperative events influence cancer recurrence risk after surgery https://doi.org/10.1038/nrclinonc.2017.194
Reducing the risk of post-surgical cancer recurrence https://doi.org/10.2217/fon-2017-0635
Perioperative COX-2 and β-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients https://doi.org/10.1158/1078-0432.CCR-17-0152
Impact of propofol-based TIVA versus inhalational anesthesia on overall survival following cancer surgery https://pubmed.ncbi.nlm.nih.gov/35837948/
Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia https://doi.org/10.1016/j.bja.2018.10.014
ERAS Society Guidelines https://erassociety.org/guidelines
The anti-proliferative effects of a frankincense extract in a window of opportunity Phase Ia clinical trial for patients with breast cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC10959833/
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.25945
Boswellia serrata for cerebral radiation necrosis after radiosurgery for brain metastases https://www.redjournal.org/article/S0360-3016(25)00153-1/fulltext
Exploring the promising therapeutic benefits of iodine and cancer https://pmc.ncbi.nlm.nih.gov/articles/PMC11731950/
Systematic review and meta-analysis of the effect of zinc on wound healing https://pmc.ncbi.nlm.nih.gov/articles/PMC12322555/
A Systematic Review on the Role of Vitamin C in Tissue Healing https://pmc.ncbi.nlm.nih.gov/articles/PMC9405326/
Treatment with supplementary arginine, vitamin C and zinc in patients with pressure ulcers https://doi.org/10.1016/j.clnu.2005.09.009
Herbal Medicines and Perioperative Care https://doi.org/10.1001/jama.286.2.208
Related pages
Related FB group discussion thread (older thread title): Surgery Pre and Post Do's and Don'ts
This page is educational only.
It is not medical advice.
Always review perioperative medication, supplement, and anaesthesia decisions with your surgeon, anaesthetist, oncologist, and any integrative practitioner involved.
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
Last updated
Was this helpful?